Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice (Q40862031)

24 September 2017

1 reference

title

Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice (English)

1 reference

24 September 2017

R Vassallo

1

1 reference

PubMed ID

9559039

24 September 2017

J J Lipsky

series ordinal

2

1 reference

PubMed ID

9559039

24 September 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

24 September 2017

1 reference

24 September 2017

73

1 reference

24 September 2017

4

1 reference

24 September 2017

346-354

1 reference

On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline in the management of asthma: time for reappraisal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Partial purification and characterization of cyclic nucleotide phosphodiesterases from human bronchial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

PDE isoenzymes as targets for anti-asthma drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Relationships between adenosine, cyclic nucleotides, and xanthines in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Adenosine causes contractions in spiral strips and relaxations in transverse strips of guinea-pig trachea: studies on mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Functional characterization of three adenosine receptor types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The effect of centrally administered adenosine on fetal breathing movements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline stimulates fetal breathing movements during hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Stimulation of endogenous catecholamine release by theophylline: a proposed additional mechanism of action for theophylline effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Plasma catecholamine concentrations during a 72-hour aminophylline infusion in children with acute asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Mechanism of action of methylxanthines in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Diltiazem, verapamil, and nifedipine inhibit theophylline-enhanced diaphragmatic contractility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Mechanism of theophylline-induced inotropic effects on foreshortened canine diaphragm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Eosinophilic Inflammation in Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The eosinophil and the pathophysiology of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The eosinophil and bronchial asthma: current understanding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline at therapeutic concentration suppresses PAF-induced upregulation of Mac-1 on human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline and the immune response: in vitro and in vivo effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The effect of theophyllamine on T-lymphocyte activation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Anti-inflammatory effects of theophylline: modulation of cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline: potential antiinflammatory effects in nocturnal asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline in chronic asthma--evidence for disease-modifying properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

How much theophylline is enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The value of maintenance theophylline in steroid-dependent asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

What role for theophylline?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Evolving role of theophylline for treatment of chronic childhood asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Aminophylline is effective on acute exacerbations of asthma in adults--objective improvements in peak flow, spirogram, arterial blood gas measurements and lung sounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Aminophylline toxicity--how many hospital asthma deaths does it cause?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Two new roles for theophylline in the asthmatic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Efficacy of theophylline in "irreversible" airflow obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effect of aminophylline on the human diaphragm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline and diaphragmatic contractility. Investigation of a dose-response relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Increased hypoxic ventilatory drive due to administration of aminophylline in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Favorable cardiovascular effects of theophylline in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Hemodynamic effects of aminophylline in chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline and mucociliary clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

The use of theophylline in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Use of theophylline in the treatment of COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Changing practices in COPD. A new pharmacologic treatment algorithm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline in the ambulatory treatment of chronic obstructive lung disease: resolving a controversy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Management of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Value of theophylline treatment in patients handicapped by chronic obstructive lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Pathogenesis of apnea in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline in obstructive sleep apnea. A double-blind evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effect of theophylline on sleep-disordered breathing in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline reverses high-grade atrioventricular block resulting from cardiac transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Aminophylline for angina pectoris. Boon or bust?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Effect of theophylline on exercise-induced myocardial ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Exercise capacity after acute aminophylline administration in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Bidirectional effects of aminophylline on myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Nephrotoxicity from contrast media: attenuation with theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Nephrotoxicity from contrast media: attenuation with theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Role of adenosine in the renal responses to contrast medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Nephrotoxicity from contrast media: attenuation with theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Ca2+ and cyclic adenosine monophosphate involvement in radiographic contrast medium-induced renal vasoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline modulates erythrocytosis after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Induction of apoptosis in fibroblasts by c-myc protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Control of systemic capillary leak syndrome with aminophylline and terbutaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

Theophylline-induced alterations in cellular immunity in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Need for theophylline in severe steroid-requiring asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963701-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(11)63701-4

1 reference

24 September 2017

1 reference

PubMed ID

9559039